FDA To Assess Gaps Between Drug Review And Product Label Content
Executive Summary
FDA will evaluate drug review documents and approved product labeling for gaps in information as part of a quality assurance effort for drug reviews in the Center for Drug Evaluation & Research.
You may also be interested in...
FDA Employees Not Required to Concur On Approvals - Union Agreement
FDA employees are no longer required to indicate concurrence on an approval document with which they disagree under the new ratified contract of the National Treasury Employees Union FDA chapter.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011